Sign in
Genetic & Genomic MedicineHuman Genetics and Genomics Advances
Peer-reviewed journal article

Differential inclusion of NEB exons 143 and 144 provides insight into NEB-related myopathy variant interpretation and disease manifestation

Sarah SilversteiniD, Rotem OrbachiD, Safoora B. SyedaiD, Aileen Reghan FoleyiD, Svetlana GorokhovaiD, Katherine G. MeilleuriD, Meganne E. LeachiD, Prech UapinyoyingiD, Katherine R. ChaoiD, Sandra C. DonkervoortiD, Carsten G. BönnemanniD

Abstract

Biallelic pathogenic variants in the gene encoding nebulin (NEB) are a known cause of congenital myopathy. We present two individuals with congenital myopathy and compound heterozygous variants (NM_001271208.2: c.2079C>A; p.(Cys693Ter) and c.21522+3A>G) in NEB. Transcriptomic sequencing on patient muscle revealed that the extended splice variant c.21522+3A>G causes exon 144 skipping. Nebulin isoforms containing exon 144 are known to be mutually exclusive with isoforms containing exon 143, and these isoforms are differentially expressed during development and in adult skeletal muscles. Patients MRIs were compared to the known pattern of relative abundance of these two isoforms in muscle. We propose that the pattern of muscle involvement in these patients better fits the distribution of exon 144-containing isoforms in muscle than with previously published MRI findings in NEB-related disease due to other variants. To our knowledge this is the first report hypothesizing disease pathogenesis through the alteration of isoform distributions in muscle.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISSagath '24Karimi '23McAdow '22Dofash '22Laitila '24Wang '21
72% semantic matchGenetic & Genomic Medicine
Lydia Sagath, K. Kiiski, Kireshnee Naidu+28 more·medRxiv·Oct 4, 2024